Sit Less and Move More: Feasibility Study

September 19, 2025 updated by: Dr Bonny WONG Yee Man, Hong Kong Metropolitan University

Sit Less and Move More: A Feasibility Study on Physical Active Break Intervention and Improving Cardiometabolic Health

Intervention aiming to improve cardiometabolic health and physical function by reducing prolonged sitting

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Hong Kong
      • Ho Man Tin, Hong Kong
        • Recruiting
        • School of Nursing and Health Studies, Hong Kong Metropolitan University
        • Contact:
        • Principal Investigator:
          • Bonny YM Wong, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. are community-dwelling older adults aged 65 years or above,
  2. are smartphone users,
  3. sit for >= 6 hours per day
  4. are overweight

Exclusion Criteria:

  1. are unable to walk independently with/without walking aids due to a physical disability;
  2. have health conditions that hinder the adherence to intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: activity group
Behavioral: physical activity
workshops and mobile apps: break sedentary behavior by activity breaks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention feasibility
Time Frame: T2: post-intervention (week 12)
will be assessed using a scale "Feasibility, appropriateness, and acceptability of the intervention"
T2: post-intervention (week 12)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sedentary behavior
Time Frame: T1: baseline (before the study begins)
will be assessed using an accelerometer
T1: baseline (before the study begins)
Sedentary behavior
Time Frame: T2: post-intervention (week 12)
will be assessed using an accelerometer
T2: post-intervention (week 12)
Sarcopenia score ranged from 0 to 20
Time Frame: T1: baseline (before the study begins)
will be assessed using the Strength, Assistance with walking, Rise from a chair, Climb stairs and (Calf) Falls (SARC-Calf)
T1: baseline (before the study begins)
Sarcopenia score ranged from 0 to 20
Time Frame: T2: post-intervention (week 12)
will be assessed using the Strength, Assistance with walking, Rise from a chair, Climb stairs and (Calf) Falls (SARC-Calf)
T2: post-intervention (week 12)
Blood glucose
Time Frame: T1: baseline (before the study begins)
will be assessed using a portable blood monitoring device
T1: baseline (before the study begins)
Blood glucose
Time Frame: T2: post-intervention (week 12)
will be assessed using a portable blood monitoring device
T2: post-intervention (week 12)
Blood pressure
Time Frame: T1: baseline (before the study begins)
will be assessed using a portable blood monitoring device
T1: baseline (before the study begins)
Blood pressure
Time Frame: T2: post-intervention (week 12)
will be assessed using a portable blood monitoring device
T2: post-intervention (week 12)
Muscle strength (handgrip strength)
Time Frame: T1: baseline (before the study begins)
will be assessed using a hand-held dynamometer
T1: baseline (before the study begins)
Muscle strength (handgrip strength)
Time Frame: T2: post-intervention (week 12)
will be assessed using a hand-held dynamometer
T2: post-intervention (week 12)
Physical performance
Time Frame: T1: baseline (before the study begins)
will be assessed using Time-Up-to-Go (TUG)
T1: baseline (before the study begins)
Physical performance
Time Frame: T2: post-intervention (week 12)
will be assessed using Time-Up-to-Go (TUG)
T2: post-intervention (week 12)
physical function
Time Frame: T1: baseline (before the study begins)
will be assessed using Short physical performance battery (SPPB) ranging 0 to 12
T1: baseline (before the study begins)
physical function
Time Frame: T2: post-intervention (week 12)
will be assessed using Short physical performance battery (SPPB) ranging 0 to 12
T2: post-intervention (week 12)
Physical activity
Time Frame: T1: baseline (before the study begins)
will be assessed using an accelerometer
T1: baseline (before the study begins)
Physical activity
Time Frame: T2: post-intervention (week 12)
will be assessed using an accelerometer
T2: post-intervention (week 12)
Standing
Time Frame: T1: baseline (before the study begins)
will be assessed using an accelerometer
T1: baseline (before the study begins)
Standing
Time Frame: T2: post-intervention (week 12)
will be assessed using an accelerometer
T2: post-intervention (week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hong Kong Metropolitan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2025

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

May 8, 2024

First Submitted That Met QC Criteria

May 19, 2024

First Posted (Actual)

May 24, 2024

Study Record Updates

Last Update Posted (Estimated)

September 24, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RD/2022/2.12

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe